BBOT
BridgeBio Oncology
BBOT
BBOT
32 hedge funds and large institutions have $173M invested in BridgeBio Oncology in 2024 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.38% more ownership
Funds ownership: 86.59% → 86.97% (+0.38%)
Holders
32
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$520K | |
| 2 | +$367K | |
| 3 | +$126K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$73.7K |
| 5 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$27.3K |
Top Sellers
| 1 | -$1.25M | |
| 2 | -$418K | |
| 3 | -$11.9K | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$840 |
| 5 |
JPMorgan Chase & Co
New York
|
-$42 |